Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2004
08/04/2004EP1441737A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
08/04/2004EP1441732A2 Thiazole derivative and pharmaceutical use thereof
08/04/2004EP1441730A1 Hydrazono-malonitriles
08/04/2004EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
08/04/2004EP1441718A2 Carbinols for the treatment of neuropathic dysfunction
08/04/2004EP1441716A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
08/04/2004EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
08/04/2004EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
08/04/2004EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands
08/04/2004EP1150658B1 Method for controlling liposome size
08/04/2004EP1140021B1 Improved formulation for topical non-invasive application in vivo
08/04/2004EP1127071B1 Compounds with growth hormone releasing properties
08/04/2004EP1126879A4 Gene therapy for regulating smooth muscle cell tone
08/04/2004EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto
08/04/2004EP1076657B1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
08/04/2004EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen
08/04/2004EP0950059B1 Cyclic sulfone derivatives
08/04/2004CN1518559A VHH single heavy chain antibody and method for its preparation in mammal
08/04/2004CN1518552A Pyrrolopyrimidines as protein kinase inhitibors
08/04/2004CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
08/04/2004CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
08/04/2004CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
08/04/2004CN1518463A Safety shield system for prefilled syringes
08/04/2004CN1518452A Oral delivery of macromolecules
08/04/2004CN1518451A Identifying and treatment of purastic fungi of organism
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/04/2004CN1517364A Deletion type human interleukin 11 microvariant
08/04/2004CN1517117A Chinese medicine combined with acupoint treatment for curing hypertension etc. disease
08/04/2004CN1517106A Medicinal wine for treating rheumatic arthritis
08/04/2004CN1517105A Medicinal wine for treating cervical spondylopathy
08/04/2004CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid
08/04/2004CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
08/04/2004CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use
08/04/2004CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells
08/04/2004CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases
08/04/2004CN1160118C Histone containing compsn. to treat rheumatoid arthritis
08/04/2004CN1160101C Traditional Chinese medicine for treating Bi zheng due to wind-cold-dampress
08/04/2004CN1160096C Chinese medicinal capsule for treating Bi Zheng and preparation method thereof
08/04/2004CN1160076C Pharmaceutical composition comprising bisphosphonic acid
08/04/2004CN1160060C Compressed compositions comprising clarified xanthan gum
08/03/2004US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
08/03/2004US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders
08/03/2004US6770656 Amine derivatives for the treatment of apoptosis
08/03/2004US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
08/03/2004US6770643 Inhibit protein kinases
08/03/2004US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
08/03/2004US6770619 Lung surfactant compositions with dynamic swelling behavior
08/03/2004US6770281 B-cell epitope peptides of HSP 65
07/2004
07/29/2004WO2004062686A2 Therapeutic use of modulators of notch
07/29/2004WO2004062678A1 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
07/29/2004WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN
07/29/2004WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
07/29/2004WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men
07/29/2004WO2004010972A3 Pellicle-resistant gelatin capsule
07/29/2004WO2004004663A3 Compositions and methods for ligament growth and repair
07/29/2004WO2003086317A3 Protein a compositions and methods of use
07/29/2004WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
07/29/2004WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/29/2004WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
07/29/2004WO2002069883A3 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders
07/29/2004US20040147904 Methods and devices for delivery of agents to breast milk ducts
07/29/2004US20040147788 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands
07/29/2004US20040147745 Novel compounds and compositions as protease inhibitors
07/29/2004US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis
07/29/2004US20040147730 Inhibitors against galectins
07/29/2004US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering
07/29/2004US20040147600 Mixture of drug with insulin; antidiabetic agents
07/29/2004US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
07/29/2004US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders
07/29/2004US20040147573 Metalloproteinase inhibitors
07/29/2004US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease
07/29/2004US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers
07/29/2004US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders
07/29/2004US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases
07/29/2004US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents
07/29/2004US20040147546 Heterocyclic compounds
07/29/2004US20040147542 Chemical compounds
07/29/2004US20040147530 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents
07/29/2004US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents
07/29/2004US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
07/29/2004US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists
07/29/2004US20040147516 Blocking interleukins; antiinflammatory agents; autoimmune diseases ; antiarthritic agents; osteoporosis
07/29/2004US20040147508 Biologically active methylene blue derivatives
07/29/2004US20040147490 Immunosuppressants
07/29/2004US20040147486 Antitumor, anticancer agents; osteoporosis; bone disorders; Paget's disorders
07/29/2004US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches
07/29/2004US20040147484 Compositions for delivering bisphosphonates
07/29/2004US20040147468 Immunostimulatory nucleic acid molecules
07/29/2004US20040147450 To promote bone growth in mammals
07/29/2004US20040147449 For inhibition of vascularization and for cancer therapy
07/29/2004US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria
07/29/2004US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity
07/29/2004US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders
07/29/2004US20040146593 Herbal drug composition for cartilage protection
07/29/2004US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents
07/29/2004US20040146561 Useful in the healing of refractory fracture of elderly people and diabetic or osteoporosis patients; sustained release depot preparation, which, when applied locally, can release an active ingredient gradually
07/29/2004US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier
07/29/2004DE10301917A1 Use of porphyrin precursors for photodynamic therapy of psoriasis and inflammatory skin and joint diseases
07/29/2004CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf)
07/28/2004EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production